InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: amarinbullfromchicago post# 149125

Friday, 10/12/2018 2:31:19 AM

Friday, October 12, 2018 2:31:19 AM

Post# of 424162
d-

Let's assume I am right and pps will be $25-30 before Nov 10 (for simplicity $28).

"approximately 25% relative risk reduction" is 27%: $30

Assuming that the endpoint is statistically significant, the pps on Nov 12:

- Key secondary endpoint: Composite of CV death, nonfatal MI, or nonfatal stroke: $33
Additional individual or composite endpoints (tested in order listed):
- Composite of CV death or nonfatal MI: $37
- Fatal or nonfatal MI: $40
- Nonelective coronary revascularization (defined as emergent or urgent): $42
- CV death: $50
- UA determined to be caused by myocardial ischemia by invasive/noninvasive testing and requiring emergent hospitalization: $52
- Fatal or nonfatal stroke: $55
- Total mortality: $60

[Please note: these are for Nov 12 only]

The PE RRR could be 23-24% and none of the SEs is ss (robust does not mean ss) … but I think: it isn't likely.

- - - - -

what options are you talking about? insider options should be counted at the time of an offer made, right?

The options and RSUs are (mostly) time dependent (some of them based on "event") will be vested in (e.g.) 2022 … OR … fully vested in case change of Control … but the offer itself does not mean a change of control (till it will be accepted / finalized).

Best,
G


"There are some things money can't buy. For everything else, there's AMRN."

Disclosure: I am long with this stock. I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News